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Objective: Photoselective vaporization of the prostate (PVP) is an easy-to-learn procedure which shows
promise as an alternative to transurethral resection of the prostate (TURP) in treating acute urinary
retention with benign prostatic hyperplasia (BPH). In this retrospective study, we evaluated the safety
and efﬁcacy of PVP in patients with urinary retention due to BPH.
Materials and Methods: In total, 48 male patients aged 60e87 (mean, 72) years were included in the
study. Preoperative data, postoperative outcomes, and complications were recorded in patients with
a history of urinary retention before surgery.
Results: The average prostate volume was 59.2 (range, 41.71e120.1) mL. The respective preoperative
prostate-speciﬁc antigen (PSA) level was 10.4 ng/mL, and the operative time was 45 (range, 30e90) min.
The total applied laser energy ranged 60e120 (mean, 90  25) kJ. The maximal urinary ﬂow rate after
surgery 14 mL/s, and the postvoided residual urine volume was 132 mL. Recorded surgical complications
were hematuria in 10.4% and transient urinary retention in 8.3%.
Conclusion: PVP can improve the uroﬂow and peak ﬂow rate in patients with urinary retention due to
BPH with minimal postoperative discomfort and a low rate of complications.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Male bladder outlet obstruction, a clinical syndrome caused by
enlargement of the prostate, can cause acute urinary retention.
Although a variety of surgical procedures are used to treat benign
prostate hyperplasia (BPH) in geriatric patients, each has associated
risks and limitations, and better alternatives are still needed.1e5
BPH is the most common cause of lower urinary tract syndromes
(LUTS) in men older than 50 years. Transurethral resection of the
prostate (TURP) is the gold standard for treating acute urinary
retention due to BPH. While TURP remains a good effective treat-
ment, 15e20% of patients develop a signiﬁcant complication or
mortality.3 Although it is widely used, TURP is associated with
morbidity including hyponatremia-induced TURP syndrome. Many
new techniques have been introduced as alternatives to replace this
endoscopic technique, but their comparative efﬁcacies are not wellChang Gung Bioinformatics
Gung University, 5 Fu-Shing
ciation. Published by Elsevier Taiwestablished. Although various laser surgical therapies for BPH have
been investigated, their associations with prolonged irritative
symptoms or urinary retention have limited their acceptance by
urologists.1e6
Photoselective vaporization of the prostate (PVP) is a promising
technique for resection of the prostate gland, especially in patients
with underlying diseases, such as heart disease and hyper-
tension.5e7 This prostatectomy technique, especially in patients
with a large prostate gland,6 is a safe procedure and provides
a virtually bloodless operation with immediate improvement in
voiding. The objective of this retrospective clinical study was to
evaluate the efﬁcacy and safety of PVP for bladder outlet obstruc-
tion in Foley-catheterized patients.
2. Materials and methods
This study was approved by the Institutional Review Board of
Chang Gung Memorial Hospital for the Protection of Human
Subjects and informed consent was obtained from each patient. In
total, 48male patients (aged 60e87,mean 72 years) who underwent
PVP from April 2007 to January 2009 were included in this retro-
spective study. All patients suffered from urinary retention andan LLC. Open access under CC BY-NC-ND license.
Table 1
Baseline characteristics.
Age range (mean) 60e87 (72) years





Mean prostate volume (mL) 59.2  22.7
Mean residual urine (cm3) 396 (range, 340e455)
Prostate-speciﬁc antigen (ng/mL) 10.4  2.7
International Prostate Symptom Score (mean) 20.5  7.2
Bother score (mean) 4.1  2.5
Urine retention (%) 100
Table 2
Effect of photoselective vaporization of the prostate on International Prostate
Symptom Score (IPSS), maximum ﬂow (Qmax), voiding volume, and postvoided
residual urine volume (PVR).
Preoperative 3 months 6 months 9 months
IPSS 20.5  6.0 15.6  5.5 12.5  5.3 10.5  6.5
Qmax (mL/s) nil 14.0  7.5 20.1  10.8 23.0  15.9
Voiding volume (mL) nil 120  20 170  18 220  25
PVR (mL) nil 132  98 69  87 35  38
No. of patients 48 48 48 48
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ﬁrst-time Foley catheterization; eight patients required two times,
and eight patients required three times. In addition to a complete
medical history, physical examination, serum chemistry, urinalysis,
and urine culture, all patients underwent a standard urological
examination, including prostate-speciﬁc antigen (PSA), transrectal
ultrasound measurement of the prostate, and International Prostate
Symptom Score (IPSS) without an urodynamic study. The following
formula was used for the prostate volume assessment: width
(mm)  height (mm)  craniocaudal (mm)  pi/6. The mean
prostate volume was 59.2 (range, 41.71e120.1) mL. None of the
patients had a history of prostate carcinoma. Patients with urethral
stricture, neurogenic bladder, and residual urine of more than
600 mL, urinary incontinence, urinary tract infection, or compro-
mised renal function were excluded from the study. Renal sonog-
raphy was also performed to rule out any kidney anomalies.
Fourteen (29.2%) of the patients had no previous medical
history. Eight (16.7%) patients were taking warfarin, and 16 (33.3%)
were taking aspirin. Two (4.2%) patients were prescribed heparin
for heart disease. Three (6.25%) patients had liver disease. Three
(6.25%) patients had parkinsonism. Two (4.1%) patients had
a previous history of TURP. All patients required Foley catheteri-
zation due to bladder outlet obstruction.
PVP was performed under videoendoscopic guidance in all
patients. During the procedure, the high-performance system
(HPS) with lithium tribirate at 120 W was delivered by a 6-Fr side-
ﬁring ﬁber through a 22-Fr continuous-ﬂow cystoscope. Greenlight
HPS photoselective vaporization was performed using sterile 0.9%
normal saline irrigation under spinal anesthesia. All patients were
treated with a broad-spectrum antibiotic before and after the
procedure, and were managed on an inpatient basis.
The procedure began at the bladder-neck region at the 7 o’clock
position and proceeded in a clockwise direction. The prostatic lobes
on each side were readily vaporized towithin the capsular ﬁbers by
sweeping the laser ﬁber on the tissue with an anterior-to-posterior
movement. In patients with a large median lobe, complete or
partial resection of this tissue by laser ﬁber was ﬁrst performed in
order to facilitate treatment of the lateral lobes. Apical tissue was
treated with careful attention to the verumontanum and external
sphincter. The mean duration of the procedure was 45 (range,
30e90) min. The total applied laser energy ranged 60e120 kJ, with
a mean of 90  25 kJ. The procedure was patiently carried out until
an adequate TUR-like cavity was achieved. A three-way 22-Fr
urethral catheter was inserted postoperatively and removed
within 48 hours. Postoperative efﬁcacy measures were the mean
and percent change from the baseline IPSS. A quality of life score,
Qmax, and postvoided residual urine volume (PVR) were also
measured. Patients were evaluated at 3, 6, and 9 months post-
operatively for changes in these measures, including IPSS, the peak
ﬂow rate, average ﬂow rate, and voided volume. A statistical anal-
ysis was performed using Student’s t test and Fisher’s exact test to
compare differences in variables before and after PVP.
3. Results
The average duration of the operation was 45 (range, 30e90)
min. The maximum postoperative hospital stay was 3 days. The
urethral catheter was removed in less than 48 hours in all cases,
and themean duration of catheterizationwas 15 8 (range,16e48)
hours.
Underlying conditions in the 48 patients included parkinsonism
in one, mitral valve prolapse in one, liver cirrhosis in one, and two
with previous endoscopic resection of the prostate. All patients had
acute urinary retention before surgical treatment (Table 1). Medi-
cations for treating urinary symptoms, such as a neurogenicbladder or overactive bladder, were discontinued 3 days before
surgery in such patients and reinitiated 7e10 days after surgery.
Immediately after the procedure, 38 patients reported 1e5 days
of mild dysuria for which they received no speciﬁc treatment.
Delayed mild transient hematuria (7e10 days) was reported by ﬁve
patients. Eleven patients reported urgency and hesitancy after the
procedure lasting for 10e14 days. However, none of the patients had
incontinence or newly developed impotence, or required surgery
after the procedure. Four patients required Foley re-catheterization
for transient urinary retention, which was possibly attributable to
edema after removal of the urethral catheter. None of the patients
had any signiﬁcant blood loss or any ﬂuid reabsorption. None of
the patients developed urethral stricture after the procedure.
Ten percent of the sexually active patients suffered retrograde
ejaculation. No other signiﬁcant complication was demonstrated.
Throughout the relatively long follow-up duration of 1 year, all of
the patients reported a good quality of life and great satisfaction
with their urinary stream. No patient required a repeat PVP during
the study period. Follow-up was available for all patients at 3, 6,
and 9 months (Table 2). The voided volume, peak ﬂow rate, and PVR
signiﬁcantly decreased. The IPSS steadily decreased during the
follow-up period after 9 months (p < 0.05).
4. Discussion
As PVP with the GreenLight system was previously shown to
have a favorable safety proﬁle, this study examined the efﬁcacy of
this novel technique for treating patients with acute urinary
retention. The results of the procedure depend on the amount of
energy delivered, and operators learn to apply more energy in less
time as their experience increases. Also, depending on the severity
and type of comorbidities, some patients were not treated with
optimum amounts of energy in order to reduce the intra-operative
risks. Ruzat et al3 reported that high-power KTP laser vaporization
of the prostate was an ideal one-stage procedure for patients at
high risk and for those receiving anticoagulant therapy. Bouchier-
Hayes et al8,9 demonstrated that PVP was as effective as TURP,
producing equivalent improvements in ﬂow rates and IPSS but with
markedly reduced length of hospital stay, length of catheterization,
and adverse events.
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beneﬁted from PVP with improvements in both subjective and
objective voiding parameters. PVP is quite useful in treating
geriatric patients with bladder outlet obstruction secondary to
BPH.10,11 Sometimes, it is not easy to immediately evaluate the
physical health of patients with BPH. The HPS may have a lower
risk of treating such patients as soon as possible. No previous
study evaluated the effect of PVP in treating patients with Foley
catheterization due to BPH. The risk of mortality and morbidity
will be increased by the standard TURP as there is not enough
time to evaluate the etiology in patients with acute urinary
retention. All of the selected geriatric patients in this study were
at relatively high risk to receive surgical treatment. Almost all of
the patients were catheter-free after PVP. Fundementally, safety is
the main consideration in treating geriatric patients with bladder
outlet obstruction and PVP might be emerging as a safer alter-
native to TURP.12
In conclusion, although PVP cannot entirely replace TURP, it
provides geriatric patients with another treatment option that may
reduce the rate of morbidity and mortality when a surgical proce-
dure is required for urinary retention due to BPH.References
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